Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
Br J Haematol
; 189(2): 303-312, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-32012231
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazines
/
Benzamides
/
Leukemia, Myeloid, Chronic-Phase
/
Imatinib Mesylate
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2020
Type:
Article
Affiliation country:
South Korea